Zum Inhalt springen
· Dermal Fillers
SKU 11162 · GTIN 0107640173234784

Teosyal RHA 2

In stock
Volume
2 x 1 mL
Laboratory
Teoxane
Origin
Schweiz
Indication
Facial wrinkle, volume and reconstructive correction
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

TEOSYAL RHA 2 is a sterile, transparent, non-pyrogenic, viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, with a mean molecular weight above 1 million Dalton. It is cross-linked with BDDE and contains 0.3% by mass of lidocaine hydrochloride.

At 23 mg/mL it is indicated for the correction of facial wrinkles and skin creases and to augment the volume of facial tissues, across the upper face, periorbital, midface and perioral regions. Each box contains two pre-filled syringes, each with two sterile 30G 1/2 inch needles and two traceability labels.

Key Benefits of Teosyal RHA 2

  • Corrects facial wrinkles and skin creases and augments the volume of facial tissues
  • Covers four facial regions from one reference: upper face, periorbital, midface and perioral
  • Hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%
  • Mean molecular weight above 1 million Dalton, of non-animal origin, residual BDDE below 1 ppm
  • Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
  • Two pre-filled syringes per box, each with two sterile 30G 1/2 inch needles and traceability labels
  • Estimated duration of 12 to 18 months
Key Information
Brand TEOSYAL
Manufacturer Teoxane SA
Country of Origin Switzerland
Certification CE marked 2797 for the gel. The needles supplied are CE marked 0123 for TSK or 0197 for Terumo
Ingredients Hyaluronic acid of non-animal origin 23 mg/mL, cross-linked with BDDE (degree of cross-linking below 5%), at a mean molecular weight above 1 million Dalton; lidocaine hydrochloride 0.3% by mass; residual BDDE below 1 ppm; phosphate buffer pH 7.3 q.s. ad 1 mL
Volume / Size 1 ml
Packaging 2 pre-filled syringes x 1 mL, each supplied with 2 sterile 30G 1/2 inch needles and 2 traceability labels; gel volume marked on the box and each syringe
Use Type Professional use only - injectable dermal filler with anaesthetic, for facial wrinkles, volume augmentation and reconstructive indications
Injection Depth Injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, onto the supraperiosteum, or into the subdermis or the submucosa of the red lips. Must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described
Protocol / Duration Estimated lifetime of 12 to 18 months, depending on skin type, wrinkle severity, injection area, injected volume, and patient physiology and lifestyle

Indications and Professional Use

Main indications

  • Correction of any facial wrinkles and skin creases
  • Augmentation of the volume of facial tissues
  • Therapeutic indications: reconstructive surgery, filling of depressions due to scars, and reconstruction of volumes lost by lipoatrophy in patients undergoing HIV treatment

Professional use

TEOSYAL RHA 2 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, onto the supraperiosteum, or into the subdermis or the submucosa of the red lips. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed to reach an optimal result.

Treatment areas

  • Upper face: forehead lines, forehead depression, glabellar lines, temples
  • Periorbital region: eyebrows and crow's feet
  • Midface: nasolabial folds, smiling lines and accordion lines
  • Perioral region: perioral rhytids, lips including the philtrum, marionette lines, oral commissures

Patient profile

For adults assessed as suitable by the treating practitioner. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. It must also not be used in patients with a known hypersensitivity to hyaluronic acid with a history of severe allergy or anaphylactic shock, in patients with autoimmune diseases, or in pregnant or breastfeeding women. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, in patients with cardiac diseases or undergoing treatment for heart disease (beta blockers), in patients with hepatocellular insufficiency or undergoing treatment for a liver disease, or in patients with epilepsy or porphyria. It must not be used in combination with other aesthetic procedures such as peeling, laser treatment or ultrasound-based treatment.

How Teosyal RHA 2 Works

TEOSYAL RHA 2 works through hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%. Hyaluronic acid is a major constituent of the ground substance of the dermal extracellular matrix and acts as a molecular sponge, binding water to restore volume where tissue has thinned.

The low cross-linking relative to the concentration is what defines the RHA line: enough structure to correct a wrinkle or add tissue volume, while remaining adaptable in areas that move. It covers four facial regions.

Why Order From Allpara

Allpara offers genuine, verified TEOSYAL products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.

Frequently Asked Questions

How does TEOSYAL RHA 2 differ from RHA 3?

Both carry 23 mg/mL hyaluronic acid with cross-linking below 5%, but they are placed differently. RHA 2 is for facial wrinkles and skin creases across the upper face, periorbital, midface and perioral regions, supplied with 30G needles. RHA 3 is for deep wrinkles and deep creases, adding volume in the midface and remodelling the lower face, supplied with 27G needles.

How long does TEOSYAL RHA 2 last?

The estimated in vivo lifetime is 12 to 18 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.

/ Specifications

The datasheet

Category
Dermal Fillers
Brand
TEOSYAL
Laboratory
Teoxane
SKU
11162
GTIN
0107640173234784
Format
2 x 1 mL
Origin
Schweiz
Indication
Facial wrinkle, volume and reconstructive correction
Use
Professional dermal filler with 0.3% lidocaine
/ Product details

The full file

TEOSYAL RHA 2 is a sterile, transparent, non-pyrogenic, viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, with a mean molecular weight above 1 million Dalton. It is cross-linked with BDDE and contains 0.3% by mass of lidocaine hydrochloride.

At 23 mg/mL it is indicated for the correction of facial wrinkles and skin creases and to augment the volume of facial tissues, across the upper face, periorbital, midface and perioral regions. Each box contains two pre-filled syringes, each with two sterile 30G 1/2 inch needles and two traceability labels.

Teoxane, country of origin Schweiz.

Shipped EU-wide from our EU warehouse, tracked and insured, with 24-72h dispatch. Each unit ships with batch number and expiry, held in EU bond and batch-traceable.

Store to manufacturer specification, away from direct light. Cold-chain is only used where the product requires it.

Net 30 / 60 / 90 day terms* are available to verified accounts on credit approval. Invoicing is supported in EUR, CHF and GBP.

Terms are indicative and confirmed after account review.

How does TEOSYAL RHA 2 differ from RHA 3?

Both carry 23 mg/mL hyaluronic acid with cross-linking below 5%, but they are placed differently. RHA 2 is for facial wrinkles and skin creases across the upper face, periorbital, midface and perioral regions, supplied with 30G needles. RHA 3 is for deep wrinkles and deep creases, adding volume in the midface and remodelling the lower face, supplied with 27G needles.

How long does TEOSYAL RHA 2 last?

The estimated in vivo lifetime is 12 to 18 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.

/ Quick answers

Everything a buyer asks first

How does TEOSYAL RHA 2 differ from RHA 3?
Both carry 23 mg/mL hyaluronic acid with cross-linking below 5%, but they are placed differently. RHA 2 is for facial wrinkles and skin creases across the upper face, periorbital, midface and perioral regions, supplied with 30G needles. RHA 3 is for deep wrinkles and deep creases, adding volume in the midface and remodelling the lower face, supplied with 27G needles.
How long does TEOSYAL RHA 2 last?
The estimated in vivo lifetime is 12 to 18 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.
/ FAQ

Frequently asked

Both carry 23 mg/mL hyaluronic acid with cross-linking below 5%, but they are placed differently. RHA 2 is for facial wrinkles and skin creases across the upper face, periorbital, midface and perioral regions, supplied with 30G needles. RHA 3 is for deep wrinkles and deep creases, adding volume in the midface and remodelling the lower face, supplied with 27G needles.
The estimated in vivo lifetime is 12 to 18 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.

More from Teoxane

View laboratory

Clinic alternatives

All products

Teosyal RHA 2

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

TEOSYAL RHA 2 is a sterile, transparent, non-pyrogenic, viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, with a mean molecular weight above 1 million Dalton. It is cross-linked with BDDE and contains 0.3% by mass of lidocaine hydrochloride.

At 23 mg/mL it is indicated for the correction of facial wrinkles and skin creases and to augment the volume of facial tissues, across the upper face, periorbital, midface and perioral regions. Each box contains two pre-filled syringes, each with two sterile 30G 1/2 inch needles and two traceability labels.

Key Benefits of Teosyal RHA 2

  • Corrects facial wrinkles and skin creases and augments the volume of facial tissues
  • Covers four facial regions from one reference: upper face, periorbital, midface and perioral
  • Hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%
  • Mean molecular weight above 1 million Dalton, of non-animal origin, residual BDDE below 1 ppm
  • Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
  • Two pre-filled syringes per box, each with two sterile 30G 1/2 inch needles and traceability labels
  • Estimated duration of 12 to 18 months
Key Information
Brand TEOSYAL
Manufacturer Teoxane SA
Country of Origin Switzerland
Certification CE marked 2797 for the gel. The needles supplied are CE marked 0123 for TSK or 0197 for Terumo
Ingredients Hyaluronic acid of non-animal origin 23 mg/mL, cross-linked with BDDE (degree of cross-linking below 5%), at a mean molecular weight above 1 million Dalton; lidocaine hydrochloride 0.3% by mass; residual BDDE below 1 ppm; phosphate buffer pH 7.3 q.s. ad 1 mL
Volume / Size 1 ml
Packaging 2 pre-filled syringes x 1 mL, each supplied with 2 sterile 30G 1/2 inch needles and 2 traceability labels; gel volume marked on the box and each syringe
Use Type Professional use only - injectable dermal filler with anaesthetic, for facial wrinkles, volume augmentation and reconstructive indications
Injection Depth Injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, onto the supraperiosteum, or into the subdermis or the submucosa of the red lips. Must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described
Protocol / Duration Estimated lifetime of 12 to 18 months, depending on skin type, wrinkle severity, injection area, injected volume, and patient physiology and lifestyle

Indications and Professional Use

Main indications

  • Correction of any facial wrinkles and skin creases
  • Augmentation of the volume of facial tissues
  • Therapeutic indications: reconstructive surgery, filling of depressions due to scars, and reconstruction of volumes lost by lipoatrophy in patients undergoing HIV treatment

Professional use

TEOSYAL RHA 2 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, onto the supraperiosteum, or into the subdermis or the submucosa of the red lips. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed to reach an optimal result.

Treatment areas

  • Upper face: forehead lines, forehead depression, glabellar lines, temples
  • Periorbital region: eyebrows and crow's feet
  • Midface: nasolabial folds, smiling lines and accordion lines
  • Perioral region: perioral rhytids, lips including the philtrum, marionette lines, oral commissures

Patient profile

For adults assessed as suitable by the treating practitioner. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. It must also not be used in patients with a known hypersensitivity to hyaluronic acid with a history of severe allergy or anaphylactic shock, in patients with autoimmune diseases, or in pregnant or breastfeeding women. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, in patients with cardiac diseases or undergoing treatment for heart disease (beta blockers), in patients with hepatocellular insufficiency or undergoing treatment for a liver disease, or in patients with epilepsy or porphyria. It must not be used in combination with other aesthetic procedures such as peeling, laser treatment or ultrasound-based treatment.

How Teosyal RHA 2 Works

TEOSYAL RHA 2 works through hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%. Hyaluronic acid is a major constituent of the ground substance of the dermal extracellular matrix and acts as a molecular sponge, binding water to restore volume where tissue has thinned.

The low cross-linking relative to the concentration is what defines the RHA line: enough structure to correct a wrinkle or add tissue volume, while remaining adaptable in areas that move. It covers four facial regions.

Why Order From Allpara

Allpara offers genuine, verified TEOSYAL products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.

Frequently Asked Questions

How does TEOSYAL RHA 2 differ from RHA 3?

Both carry 23 mg/mL hyaluronic acid with cross-linking below 5%, but they are placed differently. RHA 2 is for facial wrinkles and skin creases across the upper face, periorbital, midface and perioral regions, supplied with 30G needles. RHA 3 is for deep wrinkles and deep creases, adding volume in the midface and remodelling the lower face, supplied with 27G needles.

How long does TEOSYAL RHA 2 last?

The estimated in vivo lifetime is 12 to 18 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.

More from Teoxane

View laboratory →

TEOSYAL RHA 2 is a sterile, transparent, non-pyrogenic, viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, with a mean molecular weight above 1 million Dalton. It is cross-linked with BDDE and contains 0.3% by mass of lidocaine hydrochloride.

At 23 mg/mL it is indicated for the correction of facial wrinkles and skin creases and to augment the volume of facial tissues, across the upper face, periorbital, midface and perioral regions. Each box contains two pre-filled syringes, each with two sterile 30G 1/2 inch needles and two traceability labels.

Teoxane, country of origin Schweiz.

Shipped EU-wide from our EU warehouse, 24-72h dispatch, tracked and insured. Each unit ships with batch number and expiry, held in EU bond and batch-traceable. Store to manufacturer specification.

Net 30 / 60 / 90 day terms* for verified accounts on credit approval. Invoicing in EUR, CHF and GBP.

How does TEOSYAL RHA 2 differ from RHA 3?

Both carry 23 mg/mL hyaluronic acid with cross-linking below 5%, but they are placed differently. RHA 2 is for facial wrinkles and skin creases across the upper face, periorbital, midface and perioral regions, supplied with 30G needles. RHA 3 is for deep wrinkles and deep creases, adding volume in the midface and remodelling the lower face, supplied with 27G needles.

How long does TEOSYAL RHA 2 last?

The estimated in vivo lifetime is 12 to 18 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.

* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.